Epilepsy Center | Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Epilepsy Center

  • 1-617-355-7970
  • International: +1-617-355-5209

The following clinical research trials are now enrolling patients:

Benign rolandic epilepsyAnchor

This study, led by Katrina Boyer, MD, and Masanori Takeoka, MD, is recruiting children with BRE, age 6-11, to investigate whether interictal epileptiform discharges are associated with cognitive and behavioral deficits. To be eligible, patients should have fewer than 15 seizures in the prior month, have no psychiatric or brain disorders affecting cognition or behavior, and should be taking no more than two anticonvulsants.

Children will undergo EEG studies and a neuropsychological screening. For more information contact katrina.boyer@childrens.harvard.edu or masanori.takeoka@childrens.harvard.edu.

Ohtahara syndromeAnchor

Ohtahara syndrome is an epileptic encephalopathy with onset in the newborn period, characterized bytonic spasms, partial seizures, and burst suppression on the EEG. As part of a larger study on the Genetics of Epilepsy and Related Neurological Disorders, we are enrolling children with Ohtahara syndrome and their immediate family members to investigate genetic causes.

Families can provide blood samples without traveling to Boston Children’s Hospital. For more information contact EpilepsyGenetics@Childrens.Harvard.edu.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337